Evidence map›Paper›PMID 11094078›Full record

ArticleMolecular and cellular biology2000

v-Src generates a p53-independent apoptotic signal.

B L Webb, E Jimenez, G S Martin

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

B L WebbDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California 94720, USA.
E Jimenez
G S Martin
University of California, Berkeley · US

Funding

GENETICS OF RNA TUMOR VIRUSESR37CA017542 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI MARTIN, G STEVEN · 1990 to 2010
$4.0M
GENETICS OF RNA TUMOR VIRUSESR01CA017542 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI MARTIN, G STEVEN · 1985 to 2002
$1.1M
PI 3-KINASE AND VSRC TRANSFORMATIONF32CA077915 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI WEBB, BRIAN L · 1998 to 2000
$17k
NCI NIH HHS CA17542NCI NIH HHS F32 CA077915NCI NIH HHS F32 CA77915-03NCI NIH HHS R01 CA017542NCI NIH HHS R37 CA017542
6 · The paper itself

Abstract

Evasion of apoptosis appears to be a necessary event in tumor progression. Some oncogenes, such as c-myc and E1A, induce apoptosis in the absence of survival factors. However, others, such as bcl-2 and v-src, activate antiapoptotic pathways. For v-Src, these antiapoptotic pathways are dependent on the function of Ras, phosphatidylinositol (PI) 3-kinase, and Stat3. Here we asked whether v-Src can activate a proapoptotic signal when survival signaling is inhibited. We show that when the functions of Ras and PI 3-kinase are inhibited, v-src-transformed Rat-2 fibroblasts undergo apoptosis, evidenced by loss of adherence, nuclear fragmentation, and chromosomal DNA degradation. The apoptotic response is dependent on activation of caspase 3. Under similar conditions nontransformed Rat-2 cells undergo considerably lower levels of apoptosis. Apoptosis induced by v-Src is accompanied by a loss of mitochondrial membrane potential and release of cytochrome c and is blocked by overexpression of bcl-2, indicating that it is mediated by the mitochondrial pathway. However apoptosis induced by v-Src is not accompanied by an increase in the level of p53 and is not dependent on p53 function. Thus v-Src generates a p53-independent proapoptotic signal.

Indexed as

ApoptosisCell Cycle ProteinsSignal TransductionTumor Suppressor ProteinsAmino Acid Chloromethyl KetonesAnimalsCaspase 3Caspase InhibitorsCaspasesCell Line, TransformedCulture Media, Serum-FreeCyclin-Dependent Kinase Inhibitor p27Cysteine Proteinase InhibitorsCytochrome c GroupDNA DamageEnzyme InhibitorsAmino Acid Chloromethyl Ketonesbenzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneCasp3 protein, ratCaspase 3Caspase InhibitorsCaspasesCell Cycle ProteinsCulture Media, Serum-FreeCyclin-Dependent Kinase Inhibitor p27Cysteine Proteinase InhibitorsCytochrome c GroupEnzyme InhibitorsFluorescent DyesMicrotubule-Associated ProteinsOncogene Protein pp60(v-src)Phosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProtein Precursorsras ProteinsTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID11094078
PMCPMC102184
OpenAlexW2143095057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.